23 terminated. 23 Phase 1, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 23 | Terminated 23 |
| Phase 2 | 8 | Terminated 8 |
Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants LN-145/LN-144 - Soft Tissue Sarcoma, Primary Central Nervous System Carcinoma | Phase 1 | Terminated | Iovance Biotherapeutics, Inc. | 5 | 2024-03-28 | 2026-10-16 |
| TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors 1200mg of TQB2928 injection+Anlotinib, 1800mg of TQB2928 injection+Anlotinib - Osteosarcoma, Other Solid Tumors | Phase 1 | Terminated | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 20 | 2024-02-15 | 2025-12-12 |
| A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours [225]-FPI-2059, [111In]-FPI-2058 - Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck | Phase 1 | Terminated | 3B Pharmaceuticals GmbH | 19 | 2023-02-07 | 2025-08-24 |
| Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - High Risk Neuroblastoma, Recurrent Neuroblastoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 12 | 2021-08-31 | 2026-06-30 |
| A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer Nivolumab, NKTR-214 - Ependymoma, Ewing Sarcoma | Phase 1 / Phase 2 | Terminated | Bristol-Myers Squibb | 15 | 2021-06-03 | 2023-03-24 |
| IBI188 Combination Therapy in Solid Tumors IBI188, GM-CSF, Cisplatin/Carboplatin - Solid Tumors, Lung Adenocarcinoma | Phase 1 | Terminated | Innovent Biologics (Suzhou) Co. Ltd. | 9 | 2021-05-25 | 2022-10-04 |
| Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP) Niraparib (Tablet for oral suspension), Dostarlimab, Niraparib (Tablet) - Neoplasms | Phase 1 | Terminated | GlaxoSmithKline | 47 | 2020-10-06 | 2026-01-21 |
| Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers Humanized 3F8 Bispecific Antibody, Blood draw - Neuroblastoma, Osteosarcoma | Phase 1 / Phase 2 | Terminated | Y-mAbs Therapeutics | 12 | 2019-02-22 | 2023-09-13 |
| Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors TP-1287 - Advanced Solid Tumors, Sarcoma | Phase 1 | Terminated | Sumitomo Pharma America, Inc. | 74 | 2018-12-26 | 2024-09-19 |
| A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma INCB059872 - Relapsed Ewing Sarcoma | Phase 1 | Terminated | Incyte Corporation | 25 | 2018-06-27 | 2025-10-21 |
| Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients Copanlisib (BAY806946) - Relapsed or Refractory Solid Tumors or Lymphoma in Children, Neuroblastoma | Phase 1 / Phase 2 | Terminated | Bayer | 31 | 2018-04-30 | 2023-12-04 |
| Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies CB-103 - Breast Cancer, Colorectal Cancer | Phase 1 / Phase 2 | Terminated | Cellestia Biotech AG | 79 | 2017-12-05 | 2024-01-16 |
| Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors Stereotactic Body Radiotherapy (SBRT) - Ewing Sarcoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Terminated | Dana-Farber Cancer Institute | 5 | 2017-01-01 | 2021-04-30 |
| A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Magnetic resonance high intensity focused ultrasound, Lyso-thermosensitive liposomal doxorubicin - Pediatric Cancer, Solid Tumors | Phase 1 | Terminated | AeRang Kim | 2 | 2016-10-01 | 2023-08-29 |
| TK216 in Patients With Relapsed or Refractory Ewing Sarcoma TK216 - Sarcoma, Ewing | Phase 1 / Phase 2 | Terminated | Oncternal Therapeutics, Inc | 85 | 2016-08-01 | 2025-02-12 |
| Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma Mithramycin - Ewing Sarcoma, Sarcoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 8 | 2012-05-10 | 2018-03-02 |
| Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia Eltrombopag - Sarcoma, Soft Tissue, Osteosarcoma | Phase 1 | Terminated | Duke University | 1 | 2012-04-01 | 2014-04-02 |
| A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response Dexrazoxane, Doxorubicin, Cisplatin - Osteosarcoma, Lung Metastases | Phase 1 | Terminated | University of Chicago | 2 | 2010-07-01 | 2013-12-10 |
| Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma Temsirolimus, Valproic Acid - Brain and Central Nervous System Tumors, Neuroblastoma | Phase 1 | Terminated | UNC Lineberger Comprehensive Cancer Center | 7 | 2009-11-01 | 2016-12-23 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors carboplatin, dasatinib, etoposide phosphate - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 7 | 2008-09-10 | 2026-11-04 |
Showing 20 of 23. Sign in to see all of them.
Sarcoma, Ewing (12) · Neuroblastoma (11) · Sarcoma (10) · Rhabdomyosarcoma (8) · Neoplasms (5) · Neuroectodermal Tumors, Primitive, Peripheral (5) · Central Nervous System Neoplasms (4) · Medulloblastoma (4) · Wilms Tumor (4) · Lymphoma (3) · Neoplasm Metastasis (3) · Recurrence (3) · Rhabdoid Tumor (3) · Astrocytoma (2)
Neoplasms by Histologic Type (23) · Neoplasms, Bone Tissue (23) · Neoplasms, Connective Tissue (23) · Neoplasms, Connective and Soft Tissue (22) · Neoplasms (18) · Neoplasms, Glandular and Epithelial (15) · Neoplasms by Site (13) · Neoplasms, Nerve Tissue (13) · Sarcoma (13) · Neoplasms, Germ Cell and Embryonal (12) · Neoplasms, Neuroepithelial (12) · Neuroectodermal Tumors (12) · Neuroectodermal Tumors, Primitive (12) · Myosarcoma (8) · Neoplasms, Muscle Tissue (8)
Carboplatin (2) · Cisplatin (2) · Granulocyte Colony-Stimulating Factor (2) · Ifosfamide (2) · Amifostine (1) · Bevacizumab (1) · Biopsy (1) · Blood Specimen Collection (1) · Blotting, Western (1) · Bone Marrow Transplantation (1) · Busulfan (1) · Dasatinib (1) · Dexrazoxane (1) · Doxorubicin (1) · Etoposide (1)
National Cancer Institute (NCI) (3) · Y-mAbs Therapeutics (2) · 3B Pharmaceuticals GmbH (1) · AeRang Kim (1) · Bayer (1) · Bristol-Myers Squibb (1) · Cellestia Biotech AG (1) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. (1) · City of Hope Medical Center (1) · Dana-Farber Cancer Institute (1) · Duke University (1) · GlaxoSmithKline (1) · Incyte Corporation (1) · Innovent Biologics (Suzhou) Co. Ltd. (1) · Iovance Biotherapeutics, Inc. (1)
United States (20) · Spain (3) · Australia (2) · China (2) · France (2) · Germany (2) · Italy (2) · United Kingdom (2) · Canada (1) · South Korea (1) · Switzerland (1)
Aaron Enke (1) · AeRang Kim, MD, PhD (1) · Andres Morales, MD (1) · Ba Yi (1) · Brigitte C Widemann, M.D. (1) · Crystal L Mackall, M.D. (1) · Elena Garalda, MD, PhD (1) · Fang Meiyu (1) · Fred Zheng, MD (1) · Guo Hongqian (1) · Guo Wei (1) · James Breitmeyer, MD (1)
PMID 31401903, PMID 23071222, PMID 28735378, PMID 33047248, PMID 33305087, PMID 36371226, PMID 38954782, PMID 39563886
2017 (1), 2018 (1), P30CA015704 (1), P30CA016086 (1), P30CA033572 (1), U01CA154967 (1), UM1CA228823 (1)